Arkolith/Insider Trading/MAZE/Form 4

Dandekar Atul

CSBOMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed May 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)8K$10.42$87K19K
May 4, 2026Option exercise(M)6K$10.42$62K25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 4, 2026Option exercise(M)8K—$020K
May 4, 2026Option exercise(M)6K—$028K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002050167-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML